2-chloro-N-((1R,4S,7S)-2-(4-chloroisoxazolo[5,4-c]pyridin-7-yl)-2-azabicyclo[2.2.1]heptan-7-yl)-4-(3-methyl-1H-1,2,4-triazol-1-yl)benzamide

ID: ALA4096341

PubChem CID: 137655944

Max Phase: Preclinical

Molecular Formula: C22H19Cl2N7O2

Molecular Weight: 484.35

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ncn(-c2ccc(C(=O)N[C@H]3[C@H]4CC[C@H]3N(c3ncc(Cl)c5cnoc35)C4)c(Cl)c2)n1

Standard InChI:  InChI=1S/C22H19Cl2N7O2/c1-11-26-10-31(29-11)13-3-4-14(16(23)6-13)22(32)28-19-12-2-5-18(19)30(9-12)21-20-15(7-27-33-20)17(24)8-25-21/h3-4,6-8,10,12,18-19H,2,5,9H2,1H3,(H,28,32)/t12-,18+,19-/m0/s1

Standard InChI Key:  PQCRELQHENQSGP-RQUSPXKASA-N

Molfile:  

     RDKit          2D

 35 40  0  0  0  0  0  0  0  0999 V2000
   31.5507  -21.3109    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.8809  -20.7124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4629  -20.3038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2524  -20.9559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3143  -19.5609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1851  -20.7248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9168  -21.2902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5195  -20.5758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0969  -21.2779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7336  -21.3001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3345  -20.5880    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.3127  -22.0070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4978  -21.9959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2353  -22.7675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8881  -23.2556    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.5539  -22.7855    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.2798  -21.2646    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   32.8899  -18.9770    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.6727  -18.1892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2464  -17.6072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8819  -17.9833    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.0367  -17.8174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6101  -17.2362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3932  -16.4475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5976  -16.2431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0276  -16.8258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9664  -15.8606    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.7746  -15.9815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1394  -15.2503    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.5566  -14.6773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8318  -15.0546    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.2360  -16.6230    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   35.6775  -13.8691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0355  -21.7422    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   33.1664  -19.8891    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  1  4  1  0
  4  5  1  0
  5  3  1  0
  3  6  1  0
  6  7  1  0
  7  4  1  0
  8  9  2  0
  9 13  1  0
 12 10  1  0
 10 11  2  0
 11  8  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 12  1  0
  9 17  1  0
 10  1  1  0
  5 18  1  1
 18 19  1  0
 19 20  1  0
 19 21  2  0
 20 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 20  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 27  1  0
 24 27  1  0
 26 32  1  0
 30 33  1  0
  4 34  1  6
  3 35  1  6
M  END

Alternative Forms

  1. Parent:

    ALA4096341

    ---

Associated Targets(Human)

F9 Tchem Coagulation factor IX (922 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F10 Tclin Coagulation factor X (9693 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (7708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (3974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

F9 Coagulation factor IX (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDCK-MDR1 (146 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (4264 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (618 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (810 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 484.35Molecular Weight (Monoisotopic): 483.0977AlogP: 3.82#Rotatable Bonds: 4
Polar Surface Area: 101.97Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.95CX Basic pKa: 1.62CX LogP: 3.35CX LogD: 3.35
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.47Np Likeness Score: -1.30

References

1. Sakurada I, Endo T, Hikita K, Hirabayashi T, Hosaka Y, Kato Y, Maeda Y, Matsumoto S, Mizuno T, Nagasue H, Nishimura T, Shimada S, Shinozaki M, Taguchi K, Takeuchi K, Yokoyama T, Hruza A, Reichert P, Zhang T, Wood HB, Nakao K, Furusako S..  (2017)  Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors.,  27  (11): [PMID:28408226] [10.1016/j.bmcl.2017.03.002]

Source